RecallDepth
Class II Terminated

Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37

Company
Fresenius Kabi Usa, Llc
Recall Initiated
June 25, 2021
Posted
July 14, 2021
Recall Number
D-0651-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
234,800 vials
Firm Location
Melrose Park, IL, United States

Reason for Recall

Low out of specification results for epinephrine assay.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Batch, expiry: Batch 6123435, exp 01/2022; 6124730, 6124731, exp 07/2022

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class II Drug recalls